Exagen Inc (XGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,951 | -15,278 | -8,191 | -3,752 | -15,115 |
| Depreciation Amortization | 3,234 | 2,226 | 1,211 | 482 | 1,878 |
| Accounts receivable | -3,020 | -3,257 | -6,892 | -6,893 | -1,284 |
| Accounts payable and accrued liabilities | 42 | -545 | -1,577 | 231 | 308 |
| Other Working Capital | -1,981 | -3,280 | -9,243 | -8,126 | -3,076 |
| Other Operating Activity | 8,051 | 9,522 | 11,136 | 7,387 | 4,010 |
| Operating Cash Flow | $-13,625 | $-10,612 | $-13,556 | $-10,671 | $-13,279 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -626 | -591 | -316 | -107 | -515 |
| Investing Cash Flow | $-626 | $-591 | $-316 | $-107 | $-515 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 23,672 | 23,672 | N/A | N/A |
| Debt Repayment | -21,068 | -20,887 | -20,514 | -90 | -490 |
| Common Stock Issued | 46,095 | 22,461 | 18,976 | 198 | 198 |
| Other Financing Activity | -592 | -427 | -265 | -172 | -371 |
| Financing Cash Flow | $24,435 | $24,819 | $21,869 | $-64 | $-663 |
| Beginning Cash Position | 22,236 | 22,236 | 22,236 | 22,236 | 36,693 |
| End Cash Position | 32,420 | 35,852 | 30,233 | 11,394 | 22,236 |
| Net Cash Flow | $10,184 | $13,616 | $7,997 | $-10,842 | $-14,457 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,625 | -10,612 | -13,556 | -10,671 | -13,279 |
| Capital Expenditure | -641 | -597 | -322 | -113 | -515 |
| Free Cash Flow | -14,266 | -11,209 | -13,878 | -10,784 | -13,794 |